ID   OE
AC   CVCL_J350
SY   Okayama Endometrium
DR   BioSample; SAMN03151749
DR   Wikidata; Q54931860
RX   PubMed=1246601;
RX   PubMed=4946504;
RX   PubMed=5169552;
RX   PubMed=20143388;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00082.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 19
//
RX   PubMed=1246601; DOI=10.1126/science.1246601;
RA   Nelson-Rees W.A., Flandermeyer R.R.;
RT   "HeLa cultures defined.";
RL   Science 191:96-98(1976).
//
RX   PubMed=4946504; DOI=10.20772/cancersci1959.62.6_549;
RA   Arata T., Nakazuma Y., Ogawa I., Tanaka Y., Hashimoto K.;
RT   "Establishment of a new human cell line derived from non-malignant
RT   endometrium.";
RL   Gann 62:549-552(1971).
//
RX   PubMed=5169552;
RA   Nakazuma Y., Atarashi T., Igawa I., Tanaka Y., Hashimoto K.;
RT   "New cell line (OE cell line) isolated from the human endometrium.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 23:1239-1240(1971).
//
RX   PubMed=20143388; DOI=10.1002/ijc.25242;
RA   Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A.,
RA   MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R.,
RA   Freshney R.I.;
RT   "Check your cultures! A list of cross-contaminated or misidentified
RT   cell lines.";
RL   Int. J. Cancer 127:1-8(2010).
//